Postmenopausal hormone therapy and changes in mammographic density. Duijnhoven, F.J.B van, Peeters, P.H.M., Warren, R.M., Bingham, S., Noord, P.A.H. van, Monninkhof, E.M., Grobbee, D.E. & Gils, C.H. van. Journal of Clinical Oncology, 25(11), 1323-1328. (2007)
Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C ß-Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer. Rademaker-Lakhai, J.M., Beerepoot, L.V., Mehra, N., Radema, S.A, Maanen, R. van, Vermaat, J.S., Witteveen, E.O., Visseren-Grul, C.M., Musib, L., Enas, N., Hal, G. van, Beijnen, J.H., Schellens, J.H.M. & Voest, E.E. Clinical Cancer Research, 13(15), 4474-4481. (2007)
The Chromosomal Passenger Complex Controls Spindle Checkpoint Function Independent from Its Role in Correcting Microtubule–Kinetochore Interactions. Vader, G., Cruijsen, C.W., Harn, T. van, Vromans, M.J.M., Medema, R.H. & Lens, S.M.A. Molecular Biology of the Cell, 18(11), 4553-4564. (2007)
Intensified 12-week CHOP (I-CHOP) plus G-CSF compared with standard 24-week CHOP (CHOP-21) for patients with intermediate-risk aggressive non-Hodgkin lymphoma: a phase 3 trial of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON). Verdonck, L.F., Notenboom, A., Jong, D.D. de, MacKenzie, M.A., Verhoef, G.E.G., Kramer, M.H.H., Ossenkoppele, G.J., Doorduijn, J.K., Sonneveld, P. & Imhoff, G.W. van. Blood, 109(7), 2759-2766. (2007)
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition. Verheul, H.M.W. & Pinedo, H.M. Nature Reviews Cancer, 7(6), 475-485. (2007)